CAMBRIDGE, Massachusetts and TORONTO, Ontario, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a biotechnology company focused on the generation and development of therapeutics ...
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...
New York, NY, Feb. 22, 2026 (GLOBE NEWSWIRE) -- NeuroYogaNYC, a leader in integrating yoga with scientific research, is thrilled to announce its sixth annual Neuroscience and Yoga Conference, ...
Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience Institute and Foundation proudly announce the 2026 World Neuroscience Day ...
The annual Society for Neuroscience (SfN) conference is currently underway in Chicago. Thousands of neuroscientists have gathered here to discuss the latest topics in neuroscience research. They’re ...
JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody ...
Welcome to the registration form for the 12th Annual NEURAL Conference, which will take place in person on June 24-26, 2026, at the University of Alabama at Birmingham (UAB). THIS FORM IS FOR NON-UAB ...
The MarketWatch News Department was not involved in the creation of this content. Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results